KP Tissue Inc.
TSX:KPT.TOHousehold & Personal Products
-$0.04 today
- Market cap
- $123.80M
- Beta
- 0.42
- P/E (TTM)
- 33.9
- EPS (TTM)
- $0.39
- Dividend yield
- 5.46%
Volume 0.01M
Average 0.02M
KPT.TO Net Income
Bottom-line profit after all expenses, interest, and taxes.
KP Tissue Inc.TSX: KPT.TO
Net Income · Q3 FY2025 · quarter ended Sep 2025
Net income declines year over year
Q3 FY2025 net income of CA$1.55M fell 25.8% year over year, ahead of the -39.0% change in trailing-twelve-month net income. Sequentially, it fell 39.7% from the prior quarter. Over 3 fiscal years it compounded at +25.2% a year.
Context
- Net income increased in 2 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -25.8% holds above the trailing-twelve-month pace of -39.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Net Income history
CAD · from the income statement
- Latest · FY2024
- 2.43M CAD
- Year-over-year change
- +149.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2024 | 2024-12-31 | 2.43M | +149.3% |
| FY2023 | 2023-12-31 | (4.94M) | +51.8% |
| FY2022 | 2022-12-31 | (10.25M) | -927.2% |
| FY2021 | 2021-12-31 | 1.24M | +163.4% |
| FY2020 | 2020-12-31 | (1.95M) | — |
Net Income vs competitors
How KPT.TO compares with its peers on the latest reported figures
- KPT.TO's LTM Sep 2025 net income of CA$3.89M is the highest of the 2 companies compared; the peer median is CA$2.43M.
- Its year-over-year change of -39.0% is the lowest of 2, against a peer median of -9.5%.
- Over three fiscal years its annual growth of +25.2% compares with a peer median of -13.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2025 | CA$3.89M | -39.0% | +25.2% | — | |
| LTM Mar 2026 | CA$2.43M | -9.5% | -13.2% | 1.0% | |
| Peer median (excluding KPT.TO) | CA$2.43M | -9.5% | -13.2% | 1.0% | |
Competitors are the stored peer set for KPT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Depreciation & Amortization | 197.84M | 153.43M | 115.99M | 238.61M | 264.78M |
| EBITDA | 197.84M | 153.43M | 115.99M | 238.61M | 264.78M |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (794K) | 1.12M | (12.55M) | (830K) | 2.49M |
| Income Before Tax | (794K) | 1.12M | (12.55M) | (830K) | 2.49M |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 1.16M | (118K) | (2.3M) | 4.11M | 56K |
| Net Income | (1.95M) | 1.24M | (10.25M) | (4.94M) | 2.43M |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.20) | 0.13 | (1.03) | (0.50) | 0.24 |
| EPS (Diluted) | (0.20) | 0.13 | (1.03) | (0.50) | 0.24 |
| Weighted Avg Shares | 9.7M | 9.84M | 9.94M | 9.96M | 9.98M |
| Weighted Avg Shares (Diluted) | 9.7M | 9.84M | 9.94M | 9.96M | 9.98M |
KP Tissue Inc.
TSX:KPT.TO
Intrinsic Alpha fair value
Locked
Current Price
$12.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.